BRAINSTORM CELL THERAPUTC
BCLI
BCLI was delisted on the 17th of July, 2025.
5 hedge funds and large institutions have $1.73K invested in BRAINSTORM CELL THERAPUTC in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 29 closing their positions.
3.97% less ownership
Funds ownership: 3.99% → 0.02% (-4%)
85% less funds holding
Funds holding: 34 → 5 (-29)
99% less capital invested
Capital invested by funds: $264K → $1.73K (-$262K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 29
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$61.1K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$31.1K |
| 3 |
GCM
Gunderson Capital Management
Mt. Pleasant,
South Carolina
|
-$29.1K |
| 4 |
BlackRock
New York
|
-$28.2K |
| 5 |
LWM
Liberty Wealth Management
Oakland,
California
|
-$25.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CWM
26
Cranbrook Wealth Management
Bloomfield Hills,
Michigan
| – | -$74 | -66 | Closed |
|
27
BNP Paribas Financial Markets
Paris,
France
| – | -$27 | -24 | Closed |
|
|
CIAS
28
CBIZ Investment Advisory Services
Independence,
Ohio
| – | -$15 | -13 | Closed |
|
|
WIM
29
Westside Investment Management
Santa Monica,
California
| – | -$14 | -12 | Closed |
|
30
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$11 | -10 | Closed |
|
|
CA
31
CoreCap Advisors
Southfield,
Michigan
| – | -$9 | -8 | Closed |
|
32
Fidelity Investments
Boston,
Massachusetts
| – | -$7 | -6 | Closed |
|
|
BWL
33
Bogart Wealth LLC
Mclean,
Virginia
| – | -$2 | -2 | Closed |
|
BCLI Hedge Fund Activity: Q3 2025 in Review
5 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in BRAINSTORM CELL THERAPUTC (BCLI) for Q3 2025, worth a combined $1.73K — down 99% from $264K a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of BCLI and 0 opened new positions — a net loss of 29 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Geode Capital Management, exiting entirely with an estimated $61.1K sold.
- 5 institutional investors held BRAINSTORM CELL THERAPUTC (BCLI) as of Q3 2025, down from 34 in Q2 2025.
- Funds reported $1.73K of BRAINSTORM CELL THERAPUTC stock for Q3 2025, down 99% quarter-over-quarter.
- 0 funds opened new BRAINSTORM CELL THERAPUTC positions in Q3 2025 and 29 closed out, a net change of -29 holders.
- The largest BRAINSTORM CELL THERAPUTC seller in Q3 2025 was Geode Capital Management, an estimated $61.1K sold.
Based on aggregated 13F filings for Q3 2025.